Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **cell death-inducing DFFA-like effector c pseudogene** is a non-functional DNA sequence in the human genome that closely resembles the *cell death-inducing DFFA-like effector c* gene (CIDEC, also known as CIDE-3, CIDE3, or FSP27) but lacks the ability to encode a functional protein[1][3][9]. Pseudogenes typically arise through gene duplication or retrotransposition followed by the accumulation of disabling mutations[1]. While most pseudogenes are transcriptionally silent and considered non-functional, some can influence the expression of their functional relatives through regulatory RNA pathways[5]. For this specific pseudogene, there is currently no evidence for a direct biological or disease-related function, nor is it considered therapeutically actionable. If the intent was to refer to the **protein-coding gene** and potential therapeutic target, the correct entry would be "cell death-inducing DFFA-like effector c (CIDEC or CIDE-3)". The pseudogene should not be considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on cell death-inducing DFFA-like effector c pseudogene.